Currently out of the existing stock ratings of Andrew Cooper, 161 are a BUY (90.45%), 17 are a HOLD (9.55%).
Analyst Andrew Cooper, currently employed at RAYMOND JAMES, has had 61.46% of price targets met with an average potential upside of 21.49%, reached in 239 days on average.
Andrew Cooper has documented 337 price targets and ratings displayed on 24 stocks. The coverage is on Healthcare, Basic Materials, Industrials sectors.
Most recent stock forecast was given on HAE, Haemonetics at 03-Sep-2026.
Analyst best performing recommendations are on NTRA (NATERA).
The best stock recommendation documented was for GH (GUARDANT HEALTH) on 7/31/2025. The price target of $61 was fulfilled within 21 days with a profit of $20.02 (48.85%), with a performance score of 23.26.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Nov-2022
$92
$14.12 (18.13%)
$81
16 days ago
(30-Oct-2026)
11/12 (91.67%)
$4.59 (5.25%)
191
Hold Since 09-Aug-2023
$46
$-31.88 (-40.93%)
$25
3 months 15 days ago
(31-Jul-2026)
11/11 (100%)
$2.29 (5.24%)
232
Hold Since 02-May-2025
$21
$-56.88 (-73.04%)
$18
8 months 21 days ago
(25-Feb-2026)
5/5 (100%)
$2.54 (13.76%)
32
Buy Since 08-Oct-2024
$22
$-6.82 (-23.66%)
$22
1 years 1 months 23 days ago
(23-Sep-2025)
5/11 (45.45%)
$6.43 (41.30%)
130
Buy Since 17-Apr-2024
$40
$-37.88 (-48.64%)
$40
1 years 6 months 10 days ago
(05-May-2025)
5/5 (100%)
$24.83 (163.68%)
523
Which stock is Andrew Cooper most bullish on?
What Year was the first public recommendation made by Andrew Cooper?
